• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.26% Nasdaq Down0.34%

    United Therapeutics Corporation (UTHR)

    -NasdaqGS
    170.88 Up 0.77(0.45%) Jul 6, 4:00PM EDT
    |After Hours : 170.88 0.00 (0.00%) Jul 6, 4:42PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 327,504   346,363   329,951   322,802  
    Cost of Revenue20,778  15,770  40,804  38,709  
    Gross Profit 306,726   330,593   289,147   284,093  
    Operating Expenses
    Research Development110,212  71,482  118,877  39,742  
    Selling General and Administrative211,340  80,534  202,507  68,031  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (14,826) 178,577   (32,237) 176,320  
    Income from Continuing Operations
    Total Other Income/Expenses Net93  (286)1,113  1,459  
    Earnings Before Interest And Taxes(14,733)178,291  (31,124)177,779  
    Interest Expense2,059  3,527  4,709  4,746  
    Income Before Tax(16,792)174,764  (35,833)173,033  
    Income Tax Expense(151)58,829  (10,596)61,181  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(16,641)115,935  (25,237)111,852  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (16,641) 115,935   (25,237) 111,852  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (16,641) 115,935   (25,237) 111,852  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.